A phase II study of S-1 monotherapy as s
A phase II study of S-1 monotherapy as second-line treatment for advanced non-small cell lung cancer
✍
Yoshitaka Totani; Yuji Saito; Masamichi Hayashi; Toshihiko Tada; Yasuo Kohashi;
📂
Article
📅
2009
🏛
Springer
🌐
English
⚖ 261 KB